Case Study –
Enclara Pharmacia
Enclara is the nation’s largest full-service pharmacy benefits manager (PBM) specifically for the hospice and palliative care sectors. Serving over 450 customers and nearly 100,000 patients nationally, Enclara works closely with hospices to reduce pharmacy costs, improve patient care and support caregivers.
Andy Horowitz, CEO
"We greatly enjoyed working with the Consonance team. They have been a critical partner throughout Enclara’s evolution over the past five years from a small hospice-focused pharmacy into a national full-service specialized pharmacy management platform."*
Initial Investment
March 2014
Partnered with founder and CEO, Andrew Horowitz to recapitalize Enclara and fund organic and inorganic growth
Transformational Public Company Carve-Out
August 2014
Acquired ExcelleRx, Inc. and PBM Holdings, two division of Omnicare (NYSE: OCR), and combined with Enclara to build the clear market leader
Strategic Partners
2014 - 2020
Made significant investments in infrastructure, processes, and new market development to support larger enterprise and drive growth
Creation of Turn-Key Health
2015 - 2020
Incubated a start-up business within Enclara, Turn-Key Health, that serves health plans, provider organizations and their members who are experiencing a serious or advanced illness through its Palliative Illness Management model to improve care quality, address costs and reduce burdens associated with life-limiting illnesses.
Turn-Key Health acquired by CareCentrix in May 2020
Tuck-In Acquisition
May 2019
In partnership with Management, Consonance sourced and closed the acquisition of Avanti Health Care Services
Acquired by Humana (NYSE: HUM)
January 2020
Humana acquires Enclara from Consonance Capital Partners
*As a result of being a former CEO of a CCP portfolio company, Andy Horowitz may have been inclined to have a favorable view of CCP.